Archive

End food and drink industry’s infiltration of UK children’s education, say experts

Written by | 8 Dec 2024

An investigation published by The BMJ today reveals widespread influence of food and drink brands in schools and nurseries – through breakfast clubs, nutrition guidance, and healthy eating campaigns – […]

Tirzepatide shows powerful diabetes-prevention effect in three-year trial

Written by | 2 Dec 2024

Tirzepatide, a new injectable weight-loss drug with the trade name Zepbound, reduced the risk of diabetes in patients with obesity and prediabetes by more than 90% over a […]

Vitamin D supplements may lower blood pressure in older people with obesity

Written by | 16 Nov 2024

Vitamin D supplements may lower blood pressure in older people with obesity and taking more than the Institutes of Medicine’s (IOM) recommended daily dose does not provide additional […]

Tirzepatide associated with greater weight loss in women than men

Written by | 1 Oct 2024

All doses of tirzepatide, a medication approved in the EU to treat type 2 diabetes and obesity, consistently reduced body weight in women and men, but women experienced […]

New blood test could be an early warning for child diabetes

Written by | 26 Sep 2024

A new type of blood test using lipids could make it easier to identify children at risk of complications around obesity including type two diabetes, liver and heart […]

Survey shows 25% of adults consider weight loss drug use without prescription

Written by | 23 Sep 2024

Injectable weight loss drugs are popular right now but can be hard to get because they are in short supply or too expensive without insurance. The result is […]

Semaglutide and tirzepatide treatment leads to weight loss in type 1 diabetes

Written by | 14 Sep 2024

Treatment with semaglutide and tirzepatide led to significant weight loss and improved blood sugar control in overweight or obese patients with type 1 diabetes (T1D). Researchers reported this […]

Sugar sweetened beverage intake among children and youths shows alarming increases worldwide

Written by | 15 Aug 2024

Children and adolescents (ages 3-19) worldwide consumed on average 23% more sugar sweetened beverages (SSBs) in 2018 than they did in 1990, researchers reported on August 7, 2024 […]

Exploding popularity of Ozempic and Wegovy among privately insured patients may worsen disparities

Written by | 5 Aug 2024

A new USC study suggests that publicly insured individuals who are most likely to benefit from new drugs for diabetes and obesity are less likely to get them than those with […]

Data shows surge in in new GLP-1RA prescriptions for obesity without type 2 diabetes

Written by | 25 Jul 2024

A nationwide study found a marked increase in new GLP-1RA prescriptions over the last decade, particularly since 2020. Semaglutide was the most prescribed GLP-1RA, by far, in 2023. […]

Specialist weight-loss services in England unable to keep up with spiralling demand

Written by | 20 Jun 2024

One in six integrated care boards (ICBs) in England have stopped accepting new patients for specialist weight management services as their referral numbers spiral out of control, an […]

Price sensitivity to unhealthy foods

Written by | 14 Jun 2024

Consumer data shows people with obesity are more price-sensitive than others when it comes to buying unhealthy foods, suggesting a food tax could be an effective public health […]

Newsletter Icon

Sign up to our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Sign Up

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.